New hope for advanced liver cancer patients with shunts
NCT ID NCT07322848
Summary
This study compares two methods of delivering chemotherapy directly to liver tumors in patients with advanced liver cancer who have previously had a TIPS shunt placed to manage complications of liver disease. Researchers want to see if using special drug-coated beads (DEB-TACE) helps patients live longer and causes fewer side effects than the conventional method (cTACE). The trial will enroll 206 participants who will be randomly assigned to receive one of the two treatments and followed for up to two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiiated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510080, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.